{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T12:12:02Z","timestamp":1785499922994,"version":"3.56.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2002,7,1]],"date-time":"2002-07-01T00:00:00Z","timestamp":1025481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Pediatrics"],"published-print":{"date-parts":[[2002,7]]},"DOI":"10.1067\/mpd.2002.125007","type":"journal-article","created":{"date-parts":[[2002,10,9]],"date-time":"2002-10-09T21:24:11Z","timestamp":1034198651000},"page":"36-44","source":"Crossref","is-referenced-by-count":49,"title":["Effect of combination antiretroviral therapy on cerebrospinal fluid HIV RNA, HIV resistance, and clinical manifestations of encephalopathy"],"prefix":"10.1067","volume":"141","author":[{"given":"Cynthia","family":"McCoig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Mercedes","family":"Castrej\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Casta\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onix","family":"de Suman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"B\u00e1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilfrido","family":"Redondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"McClernon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Danehower","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.Randall","family":"Lanier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth","family":"Hetherington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"S\u00e1ez-Llorens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Octavio","family":"Ramilo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1067\/mpd.2002.125007_bib1","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/S0022-3476(95)70397-7","article-title":"Encephalopathy in children with perinatally acquired human immunodeficiency virus infection","volume":"126","author":"Lobato","year":"1995","journal-title":"J Pediatr"},{"key":"10.1067\/mpd.2002.125007_bib2","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/S0022-3476(98)70308-7","article-title":"Encephalopathy and progression of human immunodeficiency virus disease in a cohort of children with perinatally acquired human immunodeficiency virus infection","volume":"132","author":"Cooper","year":"1998","journal-title":"J Pediatr"},{"key":"10.1067\/mpd.2002.125007_bib3","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/00006454-199804000-00016","article-title":"Neurologic manifestations of infection with HIV","volume":"17","author":"Ojukwu","year":"1998","journal-title":"Pediatr Infect Dis J"},{"key":"10.1067\/mpd.2002.125007_bib4","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1055\/s-2008-1040834","article-title":"Clinical features and treatment interventions for human immunodeficiency virus-associated neurologic disease in children","volume":"19","author":"Mintz","year":"1999","journal-title":"Semin Neurol"},{"key":"10.1067\/mpd.2002.125007_bib5","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1749-6632.1993.tb26260.x","article-title":"Neurologic syndromes","volume":"693","author":"Belman","year":"1993","journal-title":"Ann N Y Acad Sci"},{"key":"10.1067\/mpd.2002.125007_bib6","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/infdis\/174.2.288","article-title":"Virologic markers of human immunodeficiency virus type 1 in cerebrospinal fluid of infected children","volume":"174","author":"Pratt","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1067\/mpd.2002.125007_bib7","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/00006454-199808000-00019","article-title":"Neuroimaging findings in children perinatally infected with the human immunodeficiency virus","volume":"17","author":"Johann-Liang","year":"1998","journal-title":"Pediatr Infect Dis J"},{"key":"10.1067\/mpd.2002.125007_bib8","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/ana.410420504","article-title":"Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain","volume":"42","author":"McArthur","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1067\/mpd.2002.125007_bib9","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1086\/514001","article-title":"Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage","volume":"175","author":"Brew","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1067\/mpd.2002.125007_bib10","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1086\/520301","article-title":"The level of human immunodeficiency virus (HIV) type 1 RNA in cerebrospinal fluid as a marker of HIV encephalitis","volume":"26","author":"Bossi","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1067\/mpd.2002.125007_bib11","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/00042560-199512000-00005","article-title":"Quantifying HIV-1 RNA using the polymerase chain reaction on cerebrospinal fluid and serum of seropositive individuals with and without neurologic abnormalities","volume":"10","author":"Conrad","year":"1995","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1067\/mpd.2002.125007_bib12","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1021\/js990174i","article-title":"Blood-brain barrier properties of human immunodeficiency virus antiretrovirals","volume":"88","author":"Yazdanian","year":"1999","journal-title":"J Pharm Sci"},{"key":"10.1067\/mpd.2002.125007_bib13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1086\/520150","article-title":"Human immunodeficiency virus-associated dementia: review of pathogenesis, prophylaxis, and treatment studies of zidovudine therapy","volume":"29","author":"Simpson","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1067\/mpd.2002.125007_bib14","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1126\/science.3016903","article-title":"Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy","volume":"233","author":"Koenig","year":"1986","journal-title":"Science"},{"key":"10.1067\/mpd.2002.125007_bib15","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1126\/science.3277272","article-title":"The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex","volume":"239","author":"Price","year":"1988","journal-title":"Science"},{"key":"10.1067\/mpd.2002.125007_bib16","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/S0140-6736(98)07333-4","article-title":"Cerebrospinal-fluid HIV-1 RNA and drug concentrations after treatment with lamivudine plus zidovudine or stavudine","volume":"351","author":"Foudraine","year":"1998","journal-title":"Lancet"},{"key":"10.1067\/mpd.2002.125007_bib17","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1128\/AAC.41.5.1082","article-title":"1592U89, a novel carbocyclic nucleoside analog with potent, selective anti-human immunodeficiency virus activity","volume":"41","author":"Daluge","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1067\/mpd.2002.125007_bib18","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1021\/js970291i","article-title":"In vitro blood-brain barrier permeability of nevirapine compared to other HIV antiretroviral agents","volume":"87","author":"Glynn","year":"1997","journal-title":"J Pharm Sci"},{"key":"10.1067\/mpd.2002.125007_bib19","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/S0140-6736(05)63640-9","article-title":"Indinavir in cerebrospinal fluid of HIV-1-infected patients","volume":"350","author":"St\u00e5hle","year":"1997","journal-title":"Lancet"},{"key":"10.1067\/mpd.2002.125007_bib20","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1128\/AAC.44.8.2173-2175.2000","article-title":"Indinavir population pharmacokinetics in plasma and cerebrospinal fluid","volume":"44","author":"Letendre","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1067\/mpd.2002.125007_bib21","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1097\/00002030-200012220-00008","article-title":"Plasma population pharmacokinetics and penetration into cerebrospinal fluid of indinavir in combination with zidovudine and lamivudine in HIV-1-infected patients","volume":"14","author":"Zhou","year":"2000","journal-title":"AIDS"},{"key":"10.1067\/mpd.2002.125007_bib22","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/00126334-199908150-00003","article-title":"Cerebrospinal fluid HIV RNA and drug levels with combination ritonavir and saquinavir","volume":"21","author":"Kravcik","year":"1999","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1067\/mpd.2002.125007_bib23","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1172\/JCI1269","article-title":"The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors","volume":"101","author":"Kim","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1067\/mpd.2002.125007_bib24","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1093\/infdis\/174.6.1200","article-title":"Evaluation of human immunodeficiency virus (HIV) type 1 RNA levels in cerebrospinal fluid and viral resistance to zidovudine in children with HIV encephalopathy","volume":"174","author":"Sei","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1067\/mpd.2002.125007_bib25","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1542\/peds.107.1.e4","article-title":"A randomized, doubleblind study of triple nucleoside therapy of abacavir, lamivudine, and zidovudine versus lamivudine and zidovudine in previously treated human immunodeficiency virus type 1-infected children","volume":"107","author":"S\u00e1ez-Llorens","year":"2001","journal-title":"Pediatrics"},{"key":"10.1067\/mpd.2002.125007_bib26","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1001\/jama.283.18.2417","article-title":"Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an international AIDS society-USA panel","volume":"283","author":"Hirsch","year":"2000","journal-title":"JAMA"},{"key":"10.1067\/mpd.2002.125007_bib27","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/j.1651-2227.1994.tb12979.x","article-title":"Cerebrospinal fluid analysis in HIV-1-infected children: immunological and virological findings before and after AZT therapy","volume":"83","author":"Laverda","year":"1994","journal-title":"Acta Paediatr"},{"key":"10.1067\/mpd.2002.125007_bib28","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1056\/NEJM198810063191401","article-title":"Effect of continuous intravenous infusion of zidovudine (AZT) in children with symptomatic HIV infection","volume":"319","author":"Pizzo","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1067\/mpd.2002.125007_bib29","first-page":"228","article-title":"The CSF concentration\/IC50 ratio: a predictor of CNS antiretroviral (ARV) efficacy","author":"Letendre","year":"2001"},{"key":"10.1067\/mpd.2002.125007_bib30","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/00002030-199807000-00010","article-title":"Neurological disorders during HIV-1 infection correlate with viral load in cerebrospinal fluid but not with virus phenotype","volume":"12","author":"Di Stefano","year":"1998","journal-title":"AIDS"},{"key":"10.1067\/mpd.2002.125007_bib31","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/00002030-200104130-00010","article-title":"HIV-1 RNA reverse transcriptase sequence in plasma and CSF of patients with AIDS dementia complex treated with abacavir","volume":"15","author":"Lanier","year":"2001","journal-title":"AIDS"}],"container-title":["The Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347602000367?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347602000367?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T13:04:29Z","timestamp":1583413469000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022347602000367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,7]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,7]]}},"alternative-id":["S0022347602000367"],"URL":"https:\/\/doi.org\/10.1067\/mpd.2002.125007","relation":{},"ISSN":["0022-3476"],"issn-type":[{"value":"0022-3476","type":"print"}],"subject":[],"published":{"date-parts":[[2002,7]]}}}